Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway
By: Qing Su, Baolin Xu, Zhoubin Tian and Ziling Gong
Authors
Qing Su
Department of Orthopedic Oncology, Yantai Shan Hospital, Yantai, China
Baolin Xu
Department of Orthopedics, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
Zhoubin Tian
Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
Ziling Gong
Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Language: English
Page range: 389 - 402
Accepted on: Dec 14, 2021
Published on: Apr 13, 2022
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2022 Qing Su, Baolin Xu, Zhoubin Tian, Ziling Gong, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.